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a b s t r a c t
Introduction: Myelomeningocele (MMC) is congenital nervous system malformation
caused by neurulation process failure during pregnancy. The prevalence varies by the
continent, region, race, ethnicity and the time when assessed and patients present
abnormalities of different organs. One of the most severe complications is renal failure.
Aim: Clinical evaluation of patients with MMC in North-East Poland and answering the
question whether our treatment methods lead to renal function preservation. Material
and methods: Medical records of 112 patients in the period 1995–2013 were evaluated
retrospectively.
The data included: age, sex, BMI Z-score WHO, place of residence, perinatal history,
social situation, physical activity, urodynamic diagnosis, renal function, hydrocephalus
diagnosis, and functioning of shunting procedures. Results: They were no statistically
signiﬁcant differences in most studied parameters between boys and girls. We observed
statistically signiﬁcant differences among MMC patients divided into 4 groups according
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Słowa kluczowe:
 przepuklina oponowo-rdzeniowa
 badania epidemiologiczne
 pęcherz neurogenny
 czynność nerek
 aktywność ﬁzyczna
to the physical activity. They differed in birth weight and length, Apgar scale, hydrocep-
halus diagnosed and the need for ventriculoperitoneal shunt. We did not ﬁnd differences
in urodynamic diagnosis among 4 studied groups. Conclusions:
1. Data of MMC children from Poland are similar to the other countries.
2. In our opinion, early diagnostic and treatment procedure especially with early cathete-
rization of MMC children prevent renal failure development.
3. Assessment of very early markers in renal function deterioration in neurogenic blad-
der patients from widespread multicenters' research is indicated.
© 2015 Polish Pediatric Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Myelomeningocele (MMC) is congenital malformation of the
central nervous system caused by the failure of the neurula-
tion process during early pregnancy. The prevalence of MMC
varies by the continent, region, race, ethnicity, and evalua-
ted period and the rate is between 2.8 and 19.6:10 000 [1–5].
The incidents of MMC for the past 10 years have been
decreasing and such a trend is an effect of early detection
and termination of the pregnancy [6–8]. Folates administra-
tion in women is one of the reasons for decreasing
incidence of MMC [9, 10]. Patients with MMC present many
abnormalities and the most affected systems are nervous,
skeletal and urinary. Lifelong, many specialist follow-ups
should be focused on improving and/or keeping the correct
function of these organs and systems. Our prevention and
treatment should not only lead on to extending the life but
also improve the quality of life.
The aim of this study was clinical evaluation of MMC
patients in Podlasie province from January, 1995 to Decem-
ber, 2013 at the University Children's Hospital (UCH) in
Bialystok. It was our intention to evaluate the origin of MMC
children, family structures, course of the pregnancy and
childbirth, function of the urinary tract and mutual correla-
tions. We also would like to answer the question and assess
if our very detailed diagnostic process and meticulous
follow-up were appropriate and lead to preserving renal
function in MMC patients when they are susceptible to
progressive renal damage.
Material and methods
Medical records of 112 patients have been drawn from
a computerized database and were evaluated retrospecti-
vely. The data included: age, sex, place of residence,
perinatal history, social situation (living with parents, in
foster family or nursing house), physical activity assessed
using Hoffer's scale, urodynamic diagnosis, presence of the
hydrocephalus, requirement of shunting procedures (ventri-
culoperitoneal shunt – VPS), and number and kind of clinics
which they have been attending.
The physical activity of each case was graded using
Hoffer's scale (1HS – wheelchair-depended patient, 2HS –
moving with difﬁculties, 3HS – need support during moving,
4HS – moving with any problems) [11]. Urodynamic ﬁndingswere classiﬁed based on the estimation of detrusor pressure,
sphincter activity and bladder wall compliance as: neuroge-
nic detrusor overactivity (NDO), areﬂexic bladder (AB), neu-
rogenic detrusor-sphincter discoordination (NDSD), poor
bladder wall compliance (PBC) and normal bladder function
(NBF).
MMC patients have been also divided based on the
neurosurgical data according to lesion region into 3 groups:
1-thoracolumbar (Th-L), 2 – lumbar-sacral (L-S), and 3 –
sacral (S). We have also provided some demographic data
from Podlasie province – place of our patients' origin – and
divided the follow-up period into 2 parts: I – last 10 years; II
– earlier years.
Renal function based on the serum creatinine and eGFR
by the Counahan–Barratt equation [12] were estimated
twice: ﬁrst when admitted to UCH and at the last when the
patient was presented; they were studied in 4 age groups:
I – <3 years, II – 4–6 years, III – 7–15 years and IV – >15
years old. BMI Z-score WHO was calculated in all the
enrolled study patients on the time of their last stay at USK.
In order to evaluate physical development we arbitrarily
classiﬁed into grade as follow: 2 >normal <2, overweight
>2 and underweight <2 [13].
The data were collected in Microsoft Excel database.
Statistical analysis was performed using Statistica 10.0.
Values were given as medians, frequencies or percentages.
Nonparametric data were evaluated with the ANOVA analy-
sis and Wilcoxon and Mann–Whitney tests. Correlations
were assessed by Spearman test. p value less than 0,05 was
accepted as statistically signiﬁcant.
Patients and their parents were enrolled in the study
after obtaining informed consent. The study protocol was
approved by the Ethics Committee, Medical University of
Bialystok and was conducted in accordance with the Decla-
ration of Helsinki.
Results
During the study period, 120 patients were admitted because
of MMC, 8 refused participation and remaining 112 patients
formed the study group. Six patients were seen only one
time and then were lost during our follow-up. Three girls
aged 5, 7 and 17 years died during the observed period. The
cause of death was general infection and dialysis complica-
tions. A part of these patients were seen at the illness onset
and mostly they were admitted to our hospital later.
Fig. 2 – Population density in 17 consecutive districts of
Podlasie province
The data comes from Statistical Central Office report 2012
[27]
Fig. 1 – Number of newborns per 1000 population (A) versus
number of MMC newborns per 100 000 population (B) in
Podlasie province (North-East part of Poland)
The data comes from Statistical Central Office reports in the
period 1998–2012 [27]
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48 patients were born with MMC. Detailed data about
healthy children and patients with MMC are shown in Fig. 1.
The patients' origin is shown in Fig. 2. As it appears from
this graph there is one district with no MMC patient (north
part of Podlasie), next to the Lithuania border where 30%
of the population has Lithuanian origin. The most MMC
children per 100 000 population live in Łomża city and in
district nr 16. The detailed demographic data are shown
in the Table I. Most MMC children were parented by
a complete family (96/112, 85.71%). Only 2 patients (2/112,
1.79%) were living with their mother and 1 boy (1/112, 0,89%)
with his father. Four children stayed in an education
institution (4/112, 3.57%) and 3/112 (2.67%) lived with
a foster family.
The detailed antenatal and postnatal characteristics of
analyzed patients divided in physical activity groups are
shown in Table II. The median age of MMC patients was
9.13 (0.33–18) years. The median weight was 26.8 (6.45–89) kg
and length was 120 (58–177) cm. There were no differences
in these parameters between girls and boys ( p = 0.165;
p = 0.054 respectively). The patients were estimated twice:
I – in the beginning of follow-up (at ﬁrst admission to UCH)
and II – on the patient's last stay at UCH. The median age
of MMC patients during ﬁrst estimated time was 1.40 (0.10–
16.00) years and the median time of observation was 5.53
(0.1–16.33) years. We found statistically signiﬁcant differen-
ces in birth weight ( p = 0.03) and length ( p = 0.02) among
studied patients according to the Hoffer's scale. The most
children were born from the ﬁrst pregnancy, 38/92 (41.30%).
From the second were born 27/92 (29.34%), from the third
pregnancy 10/92 (10.87%), from the fourth pregnancy 9/92
(9.78) and from the ﬁfth and more were born 8/92 (8.7%).
Miscarriages were declared by10/92 (10.87%) mothers; in
2 women twice and in one case a child with anencephalia
was born. We found statistically signiﬁcant differences in
Apgar scale among the studied group ( p = 0.01). There were
no differences in gestational age ( p = 0.85) and place of the
living ( p = 0.065) between the 4 Hoffer's scale groups. Hydro-
cephalus was diagnosed in 86.1% of MMC and we founddifferences between the groups ( p < 0.001). 89% of the
patients with hydrocephalus required ventriculoperitoneal
shunt (VPS) and the differences between groups were
signiﬁcant ( p < 0.001).
VURs were diagnosed in 32.58% individuals and there
were no differences between groups ( p = 0.08). The VUR I8
was diagnosed in 24.14%, II8 in 27.59%, III8 in 17.24%, IV8 in
13.79% and V8 in 17.24% of MMC patients.
A further analysis was conducted according to the ﬁrst
urodynamic diagnosis in 92 patients. Only one child (1.09%)
had NBF during all follow-up periods. NDO were diagnosed
in 57.61% patients. Eight (8.7%) patients were diagnosed with
AB and 10.87% with NDSD. PBC had 21.74% MMC patients.
Tethered Cord Syndrome (TCS) developed in 13.04% patients.
The catheterization was necessary in majority of the
MMC patients. We estimated it during the last patient's stay
at UCH and there were no differences between the groups
( p = 0.08).
MMC patients were attending the median 7 (1–18) outpa-
tient clinics, and there were no differences between the
Table I – Demographic data of Podlasie province, North-East part of Poland
MMC
(people/100 000 population)
Population density (people/km2) Total district population District area
(km2)
1 6.1 2882 294 925 102.12
2 31.97 1921 6275 32.67
3 8.65 1060 69 331 65.24
4 11.82 48.2 143 864 2984.64
5 9.58 38.55 52 196 1353.93
6 8.31 27.6 36 120 1307.31
7 5.01 36.1 59 914 1658.27
8 8.59 42.03 58 225 1385.2
9 14.19 51 49 327 967.24
10 6.48 28.53 46 327 1623.65
11 7.52 42.46 39 903 939.73
12 7.04 30.74 42 606 1385.39
13 0 24.17 20 969 856.07
14 8.4 32.62 47 611 1459.58
15 12.6 37.67 71 411 2055
16 18.55 46.02 59 313 1288.91
17 2.2 61.37 44 990 733.11
The data comes from Central Statistical Office report, 2013 [27]. 1–17 – districts of Podlasie Province
Table II – The antenatal and postnatal characteristics of MMC patients
All patients HS 1 HS 2 HS 3 HS 4
N – number of patients; median (minimum = maximum) or (percentage within the
group)
Female/male 112; 60/52 55; 31/24 17; 7/10 12; 9/3 16; 8/8
Birth weight (kg) 92; 3.145
(1.2–4.8)
55; 3.1
(1.68–4.8)
14; 3.04
(1.2–3.95)
10; 3.33
(2.3–4.3)
13; 3.2
(2.9–4.2)
Birth length (cm) 84; 54
(40–61)
55; 52
(40–58)
7; 55
(49–58)
9; 53.5
(50–61)
13; 55
(52–61)
Type of delivery cesarean/vaginal 81; 47/34 44; 26/18 14; 11/3 11; 5/6 12; 5/7
Complicated pregnancy (%) 81; 18 (22.2) 44; 7
(15.91)
14; 6
(42.86)
11; 3
(27.27)
12; 2
(16.67)
Gestational age (weeks) 78; 40
(32–43)
43; 40
(32–42)
13; 38
(33–43)
10; 40
(35–41)
12; 40
(33–41)
Apgar scale 81; 8 (1–10) 43; 8
(1–10)
14; 8
(1–10)
11; 8
(6–10)
13; 9
(6–10)
Domicile (T/V) 100; 60/50 55; 25/30 17; 14/3 12; 6/6 16; 9/7
Hydrocephalus (%) 95; 82
(86.31)
55; 46
(83.64)
16; 14
(87.5)
9; 3
(33.33)
15; 6
(40.0)
VPS (%) 95; 59
(62.11)
55; 42
(76.36)
16; 12
(75)
9; 2
(22.22)
15; 3
(20)
VUR (%) 89; 29 (32.58) 50; 21
(38.17)
16; 3
(17.64)
11; 4
(33.33)
12; 1
(6.25)
Catheterization (%) 97; 62
(63.92)
53; 40
(75.47)
17; 9
(52.94)
12; 6
(50)
15; 7
(46.67)
Number of clinics 99; 7
(1–18)
55; 7
(1–18)
17; 7
(1–12)
12;7.5
(2–12)
15; 7
(4–12)
BMI 94; 17.9
(9.6–37.2)
55; 17.4
(9.6–37.2)
14; 20.2
(12.3–31.5)
11; 19.2
(11.8–29.3)
14; 16.7
(13.1–22.4)
BMI Z-score WHO 92; 0,45
(7.31 to 4.26)
53; 0,59
(7.31 to 2.26)
14; 1.41
(2.97 to 2.97)
11; 0,91
(3.48 to 2.65)
14; 0.07
(2.48 to 2.8)
HS, Hoffer's scale; T, town; V, village; VPS, ventriculoperitoneal shunt; VUR, vesico-ureteral reﬂux; BMI, body mass index.
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clinics. Detailed data are shown in the Fig. 3.
The median BMI Z-score WHO was 0,446 (7.307 to
4.255). There were no differences in BMI Z-score WHO
between boys and girls ( p = 0.184, p = 0.105 respectively). We
did not ﬁnd any differences in BMI Z-score WHO among
patients in Hoffer's scale ( p = 0.3) and between 2 estimatedperiods ( p = 0.46), home place ( p = 0.45), patients with hyd-
rocephalus ( p = 0.7), and type of delivery ( p = 0.54). Among
overweight patients 3.03% were obese and among under-
weight 5.05% were severe underweight.
The most frequent level of lesion was L–S in 51.79% and
the most rare was S localization (7.14%). Th-L has been
reported in 32.14% of the individuals. We found positive
Table III – Laboratory characteristics of MMC children. S creatinine – serum creatinine. I – data from the first estimation.
II – data from the last estimation, eGFR – glomerular filtration rate estimated by Counahan–Barratt equation
All patients <3 years
n = 17
3–6 years
n = 24
7–15 years
n = 50
>15 years old
n = 21
Median (minimum–maximum)
S creatinine I (mg%) 0.27 (0.11–2.49) 0.23 (0.18–0.40) 0.2 (0.16–0.51) 0.27 (0.11–2.49) 0.41 (0.23–0.77)
S creatinine II (mg%) 0.31 (0.18–8.57) 0.23 (0.18–0.31) 0.21 (0.18–0.63) 0.34 (0.18–8.57) 0.57 (0.32–1.03)
Uric acid I (mg%) 3.78 (1.29–18.03) 3.8 (2.09–5.57) 3.25 (2.29–4.25) 3.83 (1.29–8.48) 4 (2.04–6.22)
Uric acid II (mg%) 4.08 (2–9.43) 3.65 (2.00–4.91) 3.95 (2.69–5.25) 4.04 (2.08–9.43) 4.8 (3.74–7.66)
Urea I (mg%) 23.00 (7.00–98.00) 20.00 (7.00–43.00) 21.00 (8.00–57.00) 23.40 (10.00–98.00) 27.00 (10.00–38.00)
Urea II (mg%) 27.00 (12.00–212.00) 26.50 (12.00–35.00) 29.00 (19.00–40.00) 27.00 (16.00–212.00) 25.50 (10.00–40.00)
eGFR (ml/min/1.73/m2) 161.25 (4.77–313.92) 160.78 (110.97–193.51) 199.64 (64.84–249.40) 168.92 (4.77–313.90) 114.22 (71.39–204.25)
Urine osmolality 693.5 (274–1177) 574 (280–873) 696 (316–931) 732.5 (274–1177) 655 (382–960)
Fig. 3 – Number of children attending to the specialist clinics in the course of 15-year follow-up. SHD – Screening of Hip
Dysplasia
p e d i a t r i a p o l s k a 9 0 ( 2 0 1 5 ) 2 8 3 – 2 8 9 287correlation between level of lesion and physical activity
(r = 0.696; p < 0,05), between hydrocephalus and VPS with
Hoffer's scale (r = 0.391, r = 0.434 respectively; p < 0.05) and
with level of lesion (r = 0.288; r = 0.401 respectively; p < 0.05).
We did not ﬁnd correlation between level of lesion and sex
(r = 0.068, p > 0.05). Apgar scale correlated positively with
Hoffer's scale (r = 0.271, r = 0.284 respectively; p < 0.05) and
eGFR correlated negatively with the level of lesion
(r = 0.2925, r = 0.25954; p < 0.05).
Renal function deterioration was found in 10.87%
patients. Detailed laboratory data of MMC children in
respect of age are included in Table III. We found differences
between creatinine I and II ( p = 0.004), urea I and urea II
( p = 0.003) and uric acid I and II ( p = 0.01) in MMC children.
We also found differences in creatinine I, creatinine II and
eGFR among patients in the 4 age groups ( p < 0.001,p < 0.001 and p = 0.008 respectively). We did not ﬁnd any
differences in median urinary osmolality within the groups
( p = 0.62).
Discussion
Studies in this part of Europe are limited. To the best our
knowledge it was the ﬁrst large and long-time study in
North-East part of Poland. Au et al. [14] described that lesion
levels located on/above L1were more frequent in female
patients. In our study, female patients are more frequent in
HS1 group but did not correlate with lesion region. Results
of our analysis about hydrocephalus, need of VPS procedure
and TCS complication are similar to Talamonti et al. [15]
study where most patients had enlarged ventricles but only
p e d i a t r i a p o l s k a 9 0 ( 2 0 1 5 ) 2 8 3 – 2 8 928878% needed VPS and 20% patients presented TCS and also
to a Swedish study performed by Olsson et al. [16] where
hydrocephalus was seen in 86% and 31% needed surgery
because of TCS. We can speculate that the natural history of
MMC is similar despite differences in patients between
countries, ethnicities and races.
We used BMI Z-score WHO for assessing physical condi-
tion of our patients. We realize, that up to now, we do not
have a perfect tool for the measurement of physical feature
as body length in patients with scoliosis or deformation of
lower limbs. We took all dimensions of our patients in the
same, lying position. Overweight/obesity are growing prob-
lems in children of developed countries and our study
conﬁrms that this problem is also in regard with MMC
individuals.
Roach et al. [17] demonstrated that 100% patients with
thoracic level and 86% with L1–L3 were full-time wheel-
chair-dependent and 100% with sacral localization walk
without any support. In our study level of lesion correlates
positively with activity and 100% of the patients with TH-L
lesion were in 1HS scale but 12.5% patients with S level of
lesion were classiﬁed as 3HS.
The cause of death in our patients was the same as in
other studies: general infection and renal failure [17, 18].
Two girls who died during the observed period were
admitted to UCH in the end stage of renal failure. Both
the girls' parents did not respect bladder catheterization
recommendations. It is worth to underline that VURs,
areﬂexic bladder and incompetent urethral function were
diagnosed in both of them. As it was stated in Roach et al.
[17] study the mortality of MMC patients was very high
more than ﬁfty years ago and was about 20% in patients
aged 31 years. Fortunately, the mortality decreases accor-
ding to the years. Talamonti et al. [15] demonstrated that
at the end of the XX century mortality of MMC patients
was about 2%. In our observation mortality was quite low
and was 2.5%.
The results of our study are in accordance to the other
studies about the localization of MMC where the most
often is lumbar localization [19–22]; although in our study
Th-L localization was quite frequent. Bulbul et al. [18]
found Th-L level only in 7.1% patients. This difference can
result from the time of damaging factors action in
pregnancy. As is well known, the multiple initial closure is
proposed for human neurulation sequence and the onset
is estimated not later than the embryonic age day 24 [23].
The detection of the risks factors in this short time can be
impossible.
Our results about follow-up in outpatient clinics differ
compared to others. In other studies quite a big number of
MMC patients did not see a nephrologist up to the age of 4.2
years and stayed under the care of pediatricians and
urologists [24]. We have been carrying out the diagnostic
program for many years in cooperation with other specia-
lists, realizing that MMC patients are in the risks group of
chronic renal diseases. Our attitude comes from our unplea-
sant experience with not catheterized patients which ﬁnally
required renal replacement therapy. We started very early
education to refer MMC patients to a nephrologist for renal
function estimation.Commonly, we are convinced that patients with S lesion
localization have normal bladder function. Although, based
on our analysis, we can say that ﬁrstly only one patient had
correct bladder function and secondly 46% of well-activity
patients need catheterization; it is evidence that there are
plenty of patients with low lesion and incorrect bladder
function.
Proportions in urodynamically conﬁrmed lower urinary
tract abnormalities are compared to others where the NDO
was most common [25, 26]. The differences in other urody-
namic diagnoses can come from the differences between
groups and time of estimation.
Poor osmolality and lack of differences between 4 age
groups can point out to renal function damage and in
combination with higher eGFR in MMC patients can be
recognized as a very early marker of renal function deteriora-
tion. In our study like in others [20] we did not ﬁnd chronic
renal diseases in any cases at ﬁrst estimation.
Many studies have been conducted to evaluate factors
reducing the prevalence of meningomyelocele but studies
which organized to prevent or reduce renal function
deterioration are still limited. In our study, we would like
to make the assessment very early and have good coope-
ration of many specialists in our hospital. We recommend
early institution of a bladder management program and
a long-term follow-up of MMC patients. It is very impor-
tant to ﬁnd a proper way for early identiﬁcation of
children with high risk of renal failure. We should start
from pregnant women, whose children are antenatally
diagnosed with MMC and refer them to multidisciplinary,
tertiary care hospitals with multi-specialist support.
The next very important point of follow-up is annual
urodynamically estimated bladder function and nephrolo-
gist consultation to detect renal function deterioration. In
our opinion early CIC recommendation improves renal
tract function and preserves progression to renal insufﬁ-
ciency.
Our study has some limitations. Firstly, we do not have
the data concerning folic acid supplementation used by the
MMC children's mothers. We have organized the question-
naire based on the study to complement the data of MMC
children from our region. Secondly, we realized that all the
described patients cannot be with MMC from our region and
the data are not completed in all cases, but most of the
MMC patients visited our tertiary center at least once.
Additionally, we do not assess the inﬂuence of rehabilitation
procedure on the physical activity of MMC children and
neurogenic bladder function.
Conclusions
1. Data of MMC children from Poland are similar to the
other countries.
2. In our opinion, early diagnostic and treatment procedure
especially with early catheterization of MMC children
prevent renal failure development.
3. Assessment of very early markers in renal function
deterioration in neurogenic bladder patients from wides-
pread multicenters research is indicated.
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